|
|
 | | | |
- close
- close
- close
- close
These excerpts taken from the ILMN 10-K filed Feb 26, 2009. Research
and Development
We have made substantial investments in research and development
since our inception. We have assembled a team of skilled
engineers and scientists who are specialists in biology,
chemistry, informatics, instrumentation, optical systems,
software, manufacturing and other related areas required to
complete the development of our products. Our research and
development efforts have focused primarily on the tasks required
to optimize our Sequencing, BeadArray, VeraCode and Oligator
technologies and to support commercialization of the products
and services derived from these technologies. As of
December 28, 2008, we had a total of 406 employees
engaged in research and development activities.
Our research and development expenses for 2008, 2007, and 2006
(inclusive of charges relating to stock-based compensation of
$14.1 million, $10.0 million and $3.9 million,
respectively) were $100.0 million, $73.9 million and
$33.4 million, respectively. We expect research and
development expense to increase during 2009 as we continue to
expand our research and product development efforts.
Research and Development We have made substantial investments in research and development since our inception. We have assembled a team of skilled engineers and scientists who are specialists in biology, chemistry, informatics, instrumentation, optical systems, software, manufacturing and other related areas required to complete the development of our products. Our research and development efforts have focused primarily on the tasks required to optimize our Sequencing, BeadArray, VeraCode and Oligator technologies and to support commercialization of the products and services derived from these technologies. As of December 28, 2008, we had a total of 406 employees engaged in research and development activities. Our research and development expenses for 2008, 2007, and 2006 (inclusive of charges relating to stock-based compensation of $14.1 million, $10.0 million and $3.9 million, respectively) were $100.0 million, $73.9 million and $33.4 million, respectively. We expect research and development expense to increase during 2009 as we continue to expand our research and product development efforts. Research
and Development
Research and development expenses consist of costs incurred for
internal and grant-sponsored research and development. Research
and development expenses include salaries, contractor fees,
facilities costs, utilities and allocations of benefits.
Expenditures relating to research and development are expensed
in the period incurred.
Research and Development Research and development expenses consist of costs incurred for internal and grant-sponsored research and development. Research and development expenses include salaries, contractor fees, facilities costs, utilities and allocations of benefits. Expenditures relating to research and development are expensed in the period incurred. These excerpts taken from the ILMN 10-K filed Feb 26, 2008. Research and
Development
Research and development expenses consist of costs incurred for
internal and grant-sponsored research and development. Research
and development expenses include salaries, contractor fees,
facilities costs, utilities and allocations of benefits.
Expenditures relating to research and development are expensed
in the period incurred.
Research and Development Research and development expenses consist of costs incurred for internal and grant-sponsored research and development. Research and development expenses include salaries, contractor fees, facilities costs, utilities and allocations of benefits. Expenditures relating to research and development are expensed in the period incurred. This excerpt taken from the ILMN 10-K filed Feb 28, 2007. Research and
Development
Research and development expenses consist of costs incurred for
internal and grant-sponsored research and development. Research
and development expenses include salaries, contractor fees,
facilities costs, utilities and allocations of benefits.
Expenditures relating to research and development are expensed
in the period incurred.
| EXCERPTS ON THIS PAGE:
RELATED TOPICS for ILMN: |
| |||||||
